Gastrointestinal Stromal Tumors
Showing NaN - NaN of 8
Gastrointestinal Stromal Tumors Trial in Worldwide (DCC-2618, Placebo Oral Tablet)
Completed
- Gastrointestinal Stromal Tumors
- DCC-2618
- Placebo Oral Tablet
-
Scottsdale, Arizona
- +34 more
Nov 17, 2022
Gastrointestinal Stromal Tumors, Resected Gastrointestinal Stromal Tumors, Non-metastatic Trial in France (Imatinib maintenance)
Recruiting
- Gastrointestinal Stromal Tumors
- +4 more
- Imatinib maintenance
-
Marseille, Bouches Du Rhône, France
- +16 more
Jul 28, 2021
Gastrointestinal Stromal Tumors Trial in Worldwide (RAD001, Imatinib 600mg/day (Glevec is the brand name for imatinib), Imatinib
Soft-tissue Sarcoma, Gastrointestinal Stromal Tumors, Bone Sarcoma Trial in Worldwide (Quality assessment)
Unknown status
- Soft-tissue Sarcoma
- +2 more
- Quality assessment
-
Buenos Aires, Argentina
- +8 more
Feb 9, 2021
Gastrointestinal Stromal Tumors Trial in Worldwide (Nilotinib, Best Supportive Care (BSC) +/- imatinib or sunitinib)
Completed
- Gastrointestinal Stromal Tumors
- Nilotinib
- Best Supportive Care (BSC) +/- imatinib or sunitinib
-
Los Angeles, California
- +34 more
Jun 5, 2012